Resolution of severe diarrhoea and return to work in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)

被引：0

作者：

Lord H. ^{[1
,2
]}

机构：

[1] University of Montréal, Montréal, Que.

[2] Maisonneuve Rosemont, University of Montréal, Montréal, Que. HIT 2M4

来源：

Drugs | 2006年 / 66卷 / Suppl 2期

关键词：

Sirolimus; Risedronate; Mycophenolate Mofetil; Graft Function; Darbepoetin Alfa;

D O I：

10.2165/00003495-200666002-00004

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：11 / 13

页数：2

共 50 条

[21] Evaluation of Tolerability and Ability to Increase Immunosuppression in Renal Transplant Patients Converted From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium
Bilodeau, J. -F.
Montambault, P.
Wolff, J. -L.
Lemire, J.
Masse, M.
TRANSPLANTATION PROCEEDINGS, 2009, 41 (09) : 3683 - 3689
[22] Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Kyle M. Gardiner
Susan E. Tett
Christine E. Staatz
Drugs in R&D, 2018, 18 : 271 - 282
[23] Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Gardiner, Kyle M.
Tett, Susan E.
Staatz, Christine E.
DRUGS IN R&D, 2018, 18 (04) : 271 - 282
[24] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant patients: Preliminary results from the myfortic prospective multicenter study
Nashan, B
Ivens, K
Suwelack, B
Arns, W
Abbud, M
TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 521S - 523S
[25] Enteric-coated mycophenolate sodium
Gabardi, S
Tran, JL
Clarkson, MR
ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1685 - 1693
[26] Enteric-coated mycophenolate sodium
Budde, Klemens
Duerr, Michael
Liefeldt, Lutz
Neumayer, Hans-Hellmut
Glander, Petra
EXPERT OPINION ON DRUG SAFETY, 2010, 9 (06) : 981 - 994
[27] Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus
Doukaki, Spyridoula
Platamone, Andrea
Alaimo, Roberta
Bongiorno, Maria Rita
JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (01) : 67 - 72
[28] Enteric-Coated Mycophenolate SodiumTolerability Profile Compared with Mycophenolate Mofetil
Matthias Behrend
Felix Braun
Drugs, 2005, 65 : 1037 - 1050
[29] Improvement in social functioning in kidney transplant patients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®):: Three case studies
Shah, Tariq
DRUGS, 2006, 66 : 15 - 17
[30] Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil
Arns, W
Breuer, S
Choudhury, S
Taccard, G
Lee, J
Binder, V
Roettele, J
Schmouder, R
CLINICAL TRANSPLANTATION, 2005, 19 (02) : 199 - 206

← 1 2 3 4 5 →